Further, Dr. Sumyai highlighted the importance of Naloxone to increase access to opioid pain medication (morphine) for patients who suffer cancer, neuropathic and any other severe pain. During one of his missions to a Southeast Asian country, Health Ministry, Doctors and Pharmacists of the respective country reported him that there were morphine injections on the shelf of every hospital but are left to expire rather than administering them to patients in pain.
The reason behind such reluctance, as identified by the doctors was that “There was no Naloxone in the country”. Doctors and nurses were unable to administer morphine due to fear of accidental overdose and lack of Naloxone to rescue from such event.
In October 2017, the news article published in the Guardian reported that – “more than 25 million people, including 2.5 million children, die in agony every year around the world, for want of morphine or other palliative care, according to a major investigation.”
“We encourage the access to Naloxone to prevent overdose-related deaths”, said Dr. Sumyai.